Type 2 Diabetes
Conditions
Keywords
Blood pressure; Glycemic control; Metabolic health; Obesity; Personalized nutrition; Type 2 diabetes mellitus
Brief summary
Type 2 diabetes mellitus (T2DM) is a multifactorial metabolic disorder commonly accompanied by obesity, hypertension, and suboptimal glycemic control, which together increase cardiovascular risk. Conventional dietary recommendations often apply a uniform approach and may not adequately address interindividual metabolic variability. Personalized nutrition has therefore gained attention as a strategy to optimize metabolic outcomes through individualized dietary interventions. This controlled intervention study evaluated the effect of a personalized nutrition program "my plate" on metabolic parameters in patients with T2DM. Participants were assigned to either an intervention group receiving personalized dietary guidance or a control group receiving standard care. Anthropometric parameters (body weight, body mass index, and waist circumference), fasting plasma glucose, and blood pressure were assessed at baseline and after the intervention
Interventions
Personalized nutrition based on individual calorie calculation is an approach that adjusts a person's energy intake and macronutrient composition according to their estimated caloric needs derived from age, sex, body weight, height, and physical activity level.
Generalized Nutrition means giving the dietary counseling that recommended by health ministry of Indonesia
Sponsors
Study design
Eligibility
Inclusion criteria
* Male or female participants aged \>18 years * A confirmed diagnosis of type 2 diabetes mellitus based on the Fasting Blood Glucose more than 126 mg/dL * Willingness to participate in dietary counseling sessions and undergo metabolic assessments throughout the study period * Provision of written informed consent prior to participation
Exclusion criteria
* Currently following a special or therapeutic diet prescribed by a physician or dietitian * Previous receipt of dietary counseling * Presence of comorbid conditions known to affect metabolic function, as identified through a standardized screening questionnaire * Use of weight-loss medications or metabolically active dietary supplements, as determined by the screening form * Pregnancy or lactation, as assessed by medical history and physical examination
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Metabolic Profile | Baseline, and 12 weeks | Change in Fasting Plasma Glucose (mg/dL) |
Countries
Indonesia